Carbapenem-Based Antibiotics Market trends, Top Companies, Share, Growth And Forecast 2032

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Carbapenem-Based Antibiotics Global Market Report 2023 identifies product innovations as the major driver for the carbapenem-based antibiotics market's growth in the forecast period. Major companies operating in the carbapenem-based antibiotics market are innovating products to sustain their position in the market. For instance, in September 2020, Shionogi, Inc., a Japan-based discovery-based pharmaceutical company, made an announcement regarding the approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Application (sNDA) for FETROJA (cefiderocol). This approval allows for the treatment of patients aged 18 years and older who have hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP). The indication applies specifically to cases caused by susceptible Gram-negative microorganisms.

The global carbapenem-based antibiotics market size is expected to grow from $4.2 billion in 2022 to $4.43 billion in 2023 at a compound annual growth rate (CAGR) of 5.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of carbapenem-based antibiotics market is expected to reach $5.37 billion in 2027 at a CAGR of 4.9%.

Download Free Sample Of Carbapenem-Based Antibiotics Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=12035&type=smp

Major competitors in the carbapenem-based antibiotics market are Pfizer Inc., Merck & Co. Inc., Saint-Gobain S.A., Fresenius Kabi LLC, GlaxoSmithKline Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Meiji Holdings Co. Ltd., Sandoz International GmbH, Sumitomo Dainippon Pharma Co. Ltd., Shionogi & Co Ltd., Aurobindo Pharma Ltd., Acurx Pharmaceuticals, LLC, Daewoong Pharmaceutical Co. Ltd., CeramTec GmbH, ACS Dobfar S.p.A, JW Pharmaceutical Corp, Centrient Pharmaceuticals Co, Spero Therapeutics Inc., Kopran Limited, Savior Lifetec Corporation, Amedica Corporation, Flagship Biotech International Pvt. Ltd., Iterum Therapeutics plc, Cam Carbapenem-based antibiotics BV, Intelicure Lifesciences, and Ikeda Corporation.

A key trend in the carbapenem-based antibiotics market includes product innovations. Major companies operating in the carbapenem-based antibiotics market are innovating products to sustain their position in the market. For instance, in September 2020, Shionogi, Inc., a Japan-based discovery-based pharmaceutical company, made an announcement regarding the approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Application (sNDA) for FETROJA (cefiderocol). This approval allows for the treatment of patients aged 18 years and older who have hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP). The indication applies specifically to cases caused by susceptible Gram-negative microorganisms.

Read More On The Global Carbapenem-Based Antibiotics Market Report Here:
https://www.thebusinessresearchcompany.com/report/carbapenem-based-antibiotics-global-market-report

The carbapenem-based antibiotics market is segmented -
• By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types

• By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin and Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications

• By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the carbapenem-based antibiotics market.

The Business Research Company's "Global Carbapenem-Based Antibiotics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Carbapenem-Based Antibiotics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12035

The Table Of Content For The Carbapenem-Based Antibiotics Market Include:
1. Executive Summary
2. Carbapenem-Based Antibiotics Market Characteristics
3. Carbapenem-Based Antibiotics Market Trends And Strategies
4. Carbapenem-Based Antibiotics Market - Macro Economic Scenario
……
32. Global Carbapenem-Based Antibiotics Market Competitive Benchmarking
33. Global Carbapenem-Based Antibiotics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Carbapenem-Based Antibiotics Market
35. Carbapenem-Based Antibiotics Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.